Featured Question

Are there comparative data to determine clinical efficacy of each TNF inhibitor, ustekinumab, golimumab, certolizumab, apremilast, etc. for psoriatic arthritis? What are the rankings of clinical efficacy for each form of psoriatic arthritis?

See The Answer

Get the latest
science delivered
to your inbox

Answers in CME updates are
available in YOUR specialty.

Sign-up Now!

Featured Activities

06-08-2015

Individualized Treatment Selection for Patients With Type 2 Diabetes: Considering the Role of the GLP-1 Receptor Agonists in the Context of Other Therapies

Course Director
Guillermo E. Umpierrez, MD, CDE, FACP, FACE
Emory University
Grady Health System
Atlanta, Georgia

05-13-2015

Challenging Cases in Schizophrenia: Considerations for Individualized Treatment Selection

Course Director
Christoph U. Correll, MD
Hofstra North Shore LIJ School of Medicine
The Zucker Hillside Hospital
Glen Oaks, New York

05-12-2015

Current Perspectives on the Evolving Treatment Landscape in Schizophrenia and Practical Recommendations for Improving Patient Care

Course Director
Christoph U. Correll, MD
Hofstra North Shore LIJ School of Medicine
The Zucker Hillside Hospital
Glen Oaks, New York

05-06-2015

Assessing the Benefits and Limitations of the GLP-1 Receptor Agonists in the Management of Type 2 Diabetes

Course Director
Guillermo E. Umpierrez, MD, CDE, FACP, FACE
Emory University
Grady Health System
Atlanta, Georgia

04-29-2015

Current Perspectives in Management of Hypercholesterolemia: Practical Considerations for Screening and Treatment Selection

Course Director
Peter P. Toth, MD, PhD, FAAFP, FNLA, FICA, FCCP, FAHA, FACC
CGH Medical Center
Sterling, Illinois
University of Illinois
College of Medicine
Peoria, Illinois
Michigan State University
College of Osteopathic Medicine
East Lansing, Michigan
Johns Hopkins University
School of Medicine
Baltimore, Maryland

04-27-2015

New and Emerging Treatment Options for Hypercholesterolemia: Evaluating the Characteristics, Benefits, Limitations, and Potential Roles

Course Director
Peter P. Toth, MD, PhD, FAAFP, FNLA, FICA, FCCP, FAHA, FACC
CGH Medical Center
Sterling, Illinois
University of Illinois
College of Medicine
Peoria, Illinois
Michigan State University
College of Osteopathic Medicine
East Lansing, Michigan
Johns Hopkins University
School of Medicine
Baltimore, Maryland

04-17-2015

Challenging Cases in Advanced Colorectal Cancer: Considering the Latest Evidence and Patient Preferences as Part of Shared Decision-Making

Course Director
Johanna C. Bendell, MD
Sarah Cannon Research Institute/Tennessee Oncology
Nashville, Tennessee

04-15-2015

Considering the Latest Evidence and Factors to Guide Individualized Treatment Planning in Metastatic Colorectal Cancer

Course Director
Johanna C. Bendell, MD
Sarah Cannon Research Institute/Tennessee Oncology
Nashville, Tennessee

12-31-2014

Practical Considerations in Treatment Selection for Patients With Rheumatoid Arthritis

Course Director
Jeffrey Curtis, MD, MS, MPH
University of Alabama at Birmingham
UAB Arthritis Clinical Intervention Program
UAB Center for Education and Research on Therapeutics (CERTS)
UAB Pharmaco Epidemiology and Economic Research (PEER) Group
Birmingham, Alabama

12-31-2014

Practical Recommendations for Accurate Recognition and Optimal Treatment of Lennox-Gastaut Syndrome in Children

Course Director
Scott Mintzer, MD
Jefferson Comprehensive
Epilepsy Center
Thomas Jefferson University
Philadelphia, Pennsylvania